deltatrials
Active Not Recruiting NA INTERVENTIONAL 1-arm NCT05025059

Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer

The EXCitE Study: Exercise During Chemotherapy in Older Women With Early-Stage Breast Cancer

Sponsor: M.D. Anderson Cancer Center

Conditions Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage IA Breast Cancer AJCC v8 Anatomic Stage IB Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage IIA Breast Cancer AJCC v8 Anatomic Stage IIB Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IIIA Breast Cancer AJCC v8 Anatomic Stage IIIB Breast Cancer AJCC v8 Anatomic Stage IIIC Breast Cancer AJCC v8 Prognostic Stage I Breast Cancer AJCC v8 Prognostic Stage IA Breast Cancer AJCC v8 Prognostic Stage IB Breast Cancer AJCC v8 Prognostic Stage II Breast Cancer AJCC v8 Prognostic Stage IIA Breast Cancer AJCC v8 Prognostic Stage IIB Breast Cancer AJCC v8 Prognostic Stage III Breast Cancer AJCC v8 Prognostic Stage IIIA Breast Cancer AJCC v8 Prognostic Stage IIIB Breast Cancer AJCC v8 Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions Discussion Exercise Intervention Informational Intervention Medical Device Usage and Evaluation Quality-of-Life Assessment Questionnaire Administration
Updated 11 times since 2021 Last updated: Mar 3, 2026 Started: Dec 3, 2020 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05025059, this NA trial focuses on Anatomic Stage I Breast Cancer AJCC v8 and Anatomic Stage IA Breast Cancer AJCC v8 and remains ongoing. Sponsored by M.D. Anderson Cancer Center, it has been updated 11 times since 2020, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Sep 2021 – ~Jan 2022 · 4 months · monthly snapshotRecruiting~Jan 2022 – ~Sep 2022 · 8 months · monthly snapshotRecruiting~Sep 2022 – ~Oct 2023 · 13 months · monthly snapshotRecruiting~Oct 2023 – ~Apr 2024 · 6 months · monthly snapshotActive Not Recruiting~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshotActive Not Recruiting~Oct 2024 – ~Apr 2025 · 6 months · monthly snapshotActive Not Recruiting~Apr 2025 – ~Oct 2025 · 6 months · monthly snapshotActive Not Recruiting~Oct 2025 – ~Mar 2026 · 5 months · monthly snapshotActive Not Recruiting~Mar 2026 – present · 4 months · monthly snapshotActive Not Recruiting

Change History

11 versions recorded

  1. Mar 2026 — Present [monthly]

    Active Not Recruiting NA

  2. Oct 2025 — Mar 2026 [monthly]

    Active Not Recruiting NA

  3. Apr 2025 — Oct 2025 [monthly]

    Active Not Recruiting NA

  4. Oct 2024 — Apr 2025 [monthly]

    Active Not Recruiting NA

  5. Sep 2024 — Oct 2024 [monthly]

    Active Not Recruiting NA

▶ Show 6 earlier versions

  1. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  2. Apr 2024 — Jul 2024 [monthly]

    Active Not Recruiting NA

  3. Oct 2023 — Apr 2024 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  4. Sep 2022 — Oct 2023 [monthly]

    Recruiting NA

  5. Jan 2022 — Sep 2022 [monthly]

    Recruiting NA

  6. Sep 2021 — Jan 2022 [monthly]

    Recruiting NA

    First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations